By Tatum Anderson for Intellectual Property Watch One of the most vocal voices for the interests of cancer patients in India says it will use the courts to force the Indian government to declare cancer a national emergency, in an attempt to make cancer drugs affordable to sufferers. The Cancer Patients Aid Association (CPAA) wants [...]
No Comments »
Filed under: Campaign, News
Times Of India
No Comments »
Filed under: Campaign, News
By Keya Acharya , IPS news BANGALORE, Aug 27 (IPS) – Activist groups campaigning for affordable drugs will continue their boycott campaign against Swiss pharma major Novartis AG, whose controversial petition arguing that Indian patent laws violated World Trade Organisation (WTO) provisions was rejected by the Madras High Court in southern Chennai city. The reason [...]
No Comments »
Filed under: Campaign, News
THE HINDU, 13 August 2007 All further proceedings on the statutory appeals filed by Novartis, challenging the rejection of its patent application, pending before the Intellectual Property Appellate Board (IPAB) were stayed by the Madras High Court on Thursday. The First Bench comprising Chief Justice A.P. Shah and Justice P. Jyothimani granted the interim relief [...]
No Comments »
Filed under: News
BS Reporter / New Delhi August 8, 2007 The government of Switzerland will not be taking up the allegation by Novartis that Indian patent law is incompatible with the Trade-Related Aspects of Intellectual Property Rights (TRIPS) agreement at the dispute settlement board of the World Trade Organization (WTO). “We accept any case settled in India. [...]
No Comments »
Filed under: News
A division bench of the Madras High Court today dismissed a challenge to section 3(d) of the Indian Patents Act, 1970 filed by Swiss pharmaceutical multinational Novartis AG and its Indian subsidiary, Novartis India . These petitions challenged the validity of a key provision in the Indian law, which seeks to prevent ever greening and [...]
No Comments »
Filed under: News
Daily News & Analysis, August 02 ,2007 Novartis has moved the Madras High Court on Wednesday against the Intellectual Property Appellate Boards (IPAB) decision in the Glivec case, in which the company is fighting the case to obtain a patent on its anti-cancer drug. On July 20, IPAB shot down Novartis appeal to drop former [...]
No Comments »
Filed under: News
The Economic Times 2 August 2, 2007 Triggering a fresh legal wrangle, Swiss drug major Novartis on Wednesday filed a writ petition with the Madras High Court contesting the Intellectual Property Appellate Board (IPAB)s decision to let former Patent Controller General S Chandrasekaran hear its appeal for Glivec. Novartis had filed a petition with the [...]
No Comments »
Filed under: News
Economic Times, July 21, 2007 The Indian Patent Appellate Board (IPAB) has dismissed Novartis objection to the appointment of S Chandrasekaran, former Patent Controller General India, to hear its appeal for Glivec.Novartis had filed a petition with IPAB last month, insisting that the newly appointed technical member to the board had in a different capacity [...]
No Comments »
Filed under: News
Business line Wednesday, Jan 31, 2007 New Delhi Jan. 30 Health organisations from across the world have came forth in support of the Indian Government in its ongoing legal case against drug manufacturer Novartis and urged the Swiss company to drop its patent case in India. Novartis had filed an application for patenting its cancer [...]
No Comments »
Filed under: News, Patent Litigation
Novartisboycott tagged on Del.icio.us